24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
23/06/2016
Distributed Polygeneration: Barcelona Synchrotron Park Shares Its Experience
17/06/2016
Barcelona Synchrotron Park Sponsors the Fifth Ideas Generation Program
10/06/2016
The Nanoworld Is Designed and Observed In and Nearby Barcelona Synchrotron Park
02/06/2016
Mediterranean Corridor: an important infrastructure for Barcelona Synchrotron Park
26/05/2016
UAB University Makes Distance Wireless Charging a Reality
19/05/2016
HP Enters the 3D Printing Market